Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

DSpace Repository

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Author: Rommer, P. S.; Doerner, T.; Freivogel, K.; Haas, J.; Kieseier, B. C.; Kuempfel, T.; Paul, F.; Proft, F.; Schulze-Koops, H.; Schmidt, E.; Wiendl, H.; Ziemann, U.; Zettl, U. K.
Tübinger Autor(en):
Ziemann, Ulf
Published in: Journal of Neuroimmune Pharmacology (2016), Bd. 11, H. 1, S. 1-8
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s11481-015-9646-5
ISSN: 1557-1904
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)